Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience

IntroductionCardiovascular diseases (CVD) and metabolic disorders (MD) have retained leading positions in the structure of morbidity and mortality for many years. Primary hyperparathyroidism (PHPT) is also associated with a greater incidence of CVD and MD. The aim of the present study was to describ...

Full description

Bibliographic Details
Main Authors: Ekaterina A. Dobreva, Anna M. Gorbacheva, Ekaterina E. Bibik, Anna K. Eremkina, Alina R. Elfimova, Rustam Kh. Salimkhanov, Elena V. Kovaleva, Irina S. Maganeva, Natalia G. Mokrysheva
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1266728/full
_version_ 1827803411804848128
author Ekaterina A. Dobreva
Anna M. Gorbacheva
Ekaterina E. Bibik
Anna K. Eremkina
Alina R. Elfimova
Rustam Kh. Salimkhanov
Elena V. Kovaleva
Irina S. Maganeva
Natalia G. Mokrysheva
author_facet Ekaterina A. Dobreva
Anna M. Gorbacheva
Ekaterina E. Bibik
Anna K. Eremkina
Alina R. Elfimova
Rustam Kh. Salimkhanov
Elena V. Kovaleva
Irina S. Maganeva
Natalia G. Mokrysheva
author_sort Ekaterina A. Dobreva
collection DOAJ
description IntroductionCardiovascular diseases (CVD) and metabolic disorders (MD) have retained leading positions in the structure of morbidity and mortality for many years. Primary hyperparathyroidism (PHPT) is also associated with a greater incidence of CVD and MD. The aim of the present study was to describe the prevalence and structure of CVD and MD in hospitalized patients with PHPT and to search for possible associations between these pathologies.Methods838 patients with a verified PHPT were included in the study. The studied cohort was divided into 2 groups according to their age at the time of admission: patients aged 18 to 49 years (group A, n = 150); patients aged 50 years and older (group B, n = 688).ResultsThere were no significant differences between two groups in parameters of calcium-phosphorus metabolism. Obesity was diagnosed in 24.2% of patients in group A and in 35.9% in group B. Type 2 diabetes mellitus was more common in older patients (14.4% in group B vs. 2.6% in group A). Arterial hypertension, ischemic heart disease, chronic heart failure and brachiocephalic arteries atherosclerosis were more frequent in older patients, occurring in 79.1%, 10.8%, 8.4%, and 84% of cases respectively. The cutoff points that increased the risk of CVD detection turned out to be age above 56 years, eGFR below 92 ml/min/1.73m2, BMI above 28.3 kg/m2.DiscussionThe present study demonstrated a high incidence of some CVD, as well as disorders of lipid, carbohydrate and purine metabolism in patients with PHPT.
first_indexed 2024-03-11T20:54:02Z
format Article
id doaj.art-9189aeccdd9049e3864549a5557697c5
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-11T20:54:02Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-9189aeccdd9049e3864549a5557697c52023-09-30T22:07:37ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-09-011410.3389/fendo.2023.12667281266728Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experienceEkaterina A. Dobreva0Anna M. Gorbacheva1Ekaterina E. Bibik2Anna K. Eremkina3Alina R. Elfimova4Rustam Kh. Salimkhanov5Elena V. Kovaleva6Irina S. Maganeva7Natalia G. Mokrysheva8Department of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaDepartment of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, RussiaAdministration, Endocrinology Research Centre, Moscow, RussiaIntroductionCardiovascular diseases (CVD) and metabolic disorders (MD) have retained leading positions in the structure of morbidity and mortality for many years. Primary hyperparathyroidism (PHPT) is also associated with a greater incidence of CVD and MD. The aim of the present study was to describe the prevalence and structure of CVD and MD in hospitalized patients with PHPT and to search for possible associations between these pathologies.Methods838 patients with a verified PHPT were included in the study. The studied cohort was divided into 2 groups according to their age at the time of admission: patients aged 18 to 49 years (group A, n = 150); patients aged 50 years and older (group B, n = 688).ResultsThere were no significant differences between two groups in parameters of calcium-phosphorus metabolism. Obesity was diagnosed in 24.2% of patients in group A and in 35.9% in group B. Type 2 diabetes mellitus was more common in older patients (14.4% in group B vs. 2.6% in group A). Arterial hypertension, ischemic heart disease, chronic heart failure and brachiocephalic arteries atherosclerosis were more frequent in older patients, occurring in 79.1%, 10.8%, 8.4%, and 84% of cases respectively. The cutoff points that increased the risk of CVD detection turned out to be age above 56 years, eGFR below 92 ml/min/1.73m2, BMI above 28.3 kg/m2.DiscussionThe present study demonstrated a high incidence of some CVD, as well as disorders of lipid, carbohydrate and purine metabolism in patients with PHPT.https://www.frontiersin.org/articles/10.3389/fendo.2023.1266728/fullprimary hyperparathyroidismcardiovascular diseasesarterial hypertensiondiabetes mellitusdyslipidemiametabolic diseases
spellingShingle Ekaterina A. Dobreva
Anna M. Gorbacheva
Ekaterina E. Bibik
Anna K. Eremkina
Alina R. Elfimova
Rustam Kh. Salimkhanov
Elena V. Kovaleva
Irina S. Maganeva
Natalia G. Mokrysheva
Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
Frontiers in Endocrinology
primary hyperparathyroidism
cardiovascular diseases
arterial hypertension
diabetes mellitus
dyslipidemia
metabolic diseases
title Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
title_full Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
title_fullStr Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
title_full_unstemmed Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
title_short Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
title_sort cardiovascular and metabolic status in patients with primary hyperparathyroidism a single center experience
topic primary hyperparathyroidism
cardiovascular diseases
arterial hypertension
diabetes mellitus
dyslipidemia
metabolic diseases
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1266728/full
work_keys_str_mv AT ekaterinaadobreva cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT annamgorbacheva cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT ekaterinaebibik cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT annakeremkina cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT alinarelfimova cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT rustamkhsalimkhanov cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT elenavkovaleva cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT irinasmaganeva cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience
AT nataliagmokrysheva cardiovascularandmetabolicstatusinpatientswithprimaryhyperparathyroidismasinglecenterexperience